Feedback Haematology

Microspherocytic anemia. Enzymopathies

HEMOLYTIC ANEMIAS

  • Premature destruction of erythrocytes (Er)
  • ↑reticulocyte count, BR, LDH. ↓serum haptoglobin
  • Divided into intrinsic (inherited) and extrinsic (acquired)
  • 4 types of intrinsic haemolytic anemias
    • Structural haemoglobinopathies – sickle cell disease synthesis of a structurally abnormal Hb protein
    • Thalassemias – quantitative abnormality (decreased synthesis) of a globin chain
    • Enzyme defects – G6PD-D, PK-D
    • Membrane defects – hereditary spherocytosis

2. HEREDITARY SPHEROCYTOSIS (HS)

RBC Membrane

  • 3 main components
    • Phospholipid (PL) bilayer
    • Integral membrane proteins and glycoprotein – embedded in the PL bilayer
      • Important transmembrane proteins – band 3 protein and glycophorin
    • Cytoskeleton scaffold – gives RBC its shape. Mainly composed of spectrin. Ankyrin binds spectrin to band 3 protein

Epidemiology

  • MC inherited haemolytic anaemia in North Europe
  • 75% are AD

Pathophysiology

  • Defective vertical attachment between PL bilayer and the cytoskeleton scaffold
  • Results from mutations in the gene for ankyrin
  • Defective vertical attachment causes loss of PLs from the cell membrane
  • Surface area of RBC decreases and cell assumes shape of a sphere
  • Spherocytes are less flexible than normal RBCs and get trapped and destroyed in the spleen
  • Intrinsic defect with extravascular hemolysis
  • Increased permeability to Na+ and K+ means the pump is constantly running, which causes additional metabolic stress
    • Cells have an increased requirement for glucose

Clinical features

  • Highly variable
  • Neonatal hyperbilirubinemia
  • Older patients have mild/mod anaemia with hyperbilirubinemia and mild splenomegaly
  • Bilirubin gallstones
  • Pts can have exacerbations of anaemia associated with infections

Diagnosis

  • MCV is normal/low. Increase MCHC – specific for this haemolytic anaemia
  • Blood smear shows microspherocytes
  • ↑reticulocyte count
  • DAT should be done to exclude immune haemolytic anaemia
  • Osmotic fragility test – classic test for HS
    • Er incubated in saline solutions with osmolality ranging from normal to pure water
    • Percent hemolysis is measured by spectrophotometer
    • Er from HS patients hemolyse at higher saline concentration than normal cells

Treatment

  • Splenectomy, folic acid, transfusion
  • Should be delayed until 3-5 years of age due to risk of OPSI

3. ENZYME DEFECTS

Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD-D)

Epidemiology

  • One of the MC genetic diseases in the world
  • XR – men develop disease, but women are usually asymptomatic carriers
  • MC in Africa, Mediterranean, Asia

Pathophysiology

  • First enzyme in hexose monophosphate shunt, which is required to generate NADPH, which is needed for regeneration of glutathione by glutathione reductase
  • In absence of sufficient glutathione, Hb is oxidised and precipitates in the cells (Heinz bodies) – results in hemolysis
  • Aggregates of oxidised Hb are removed from the cell by the spleen, resulting in bite cells
  • Level of G6PD is highest in reticulocytes and lower in aged cells
    • In normal people the activity of the enzyme remains enough to protect older cells from oxidative stress
  • Normal G6PD half life is 62 days
    • In the common African variant of G6PD deficiency half life is 13 days

Clinical features

  • Most patients are not anaemic and have no hemolysis at baseline state
  • African variant is Class III – episodes of hemolysis are precipated by infection, oxidative drugs, chemicals, surgery
  • Episodes of hemolysis are indicated by sudden onset jaundice, pallor, dark urine, abdominal pain
  • Mediterranean variant (class II) is MC in Caucasians
    • Uncooked fava beans are common cause of hemolysis in these patients
  • Class I variants are very unstable
    • Anemia and jaundice noted in neonates

Diagnosis

  • Bite cells in peripheral smear (pic)
  • Fluorescent screening test for NADPH production
  • DAT –ve

Treatment

  • Avoid conditions that predispose to hemolysis
  • Treat infections promptly
  • Transfusions for infants with marked hyperBR

Pyruvate kinase deficiency (AR)

Epidemiology

  • MC in pts of North European and Mediterranean descent

Pathophysiology

  • Defect in Emden-Meyerhof pathway
  • Er with PK deficiency generate less ATP and NADH from glucose
  • 2,3-BPG accumulates in RBCs
    • Since ↑2,3-BPG facilities oxygen unloading, patients tolerate anaemia well and are asymptomatic despite ↓Hb ( Right shift of Hb-O2 dissociation curve >> ↑release of O2 to tissues)
  • Decreased ATP leads to cellular dehydration and formation of echinocytes

Clinical features

  • Neonatal hyperBR
  • Older children and adults – chronic hemolysis
  • Splenomegaly
  • Infections, surgery, pregnancy can precipate acute exacerbation of hemolysis
  • Aplastic crisis can occur due to infx with parvovirus B19

Diagnosis

  • enzyme assays show low PK activity
  • Blood smear shows echinocytes (pic)
  • PKLR gene mutation

Treatment

  • Transfusions for neonatal hyperBR
  • Older patients normally tolerate anaemia well so don’t require treatment
  • splenectomy
Feedback